Which segments make up the Conjugate Vaccine Market analysis?

Global health has improved significantly due to the contributions made by vaccines. Vaccines are the reason behind the eradication of the world’s major diseases, smallpox, polio, and measles. Conjugate vaccines target various deadly, yet vaccine-preventable diseases. Conjugate vaccines attach a strong antigen to a weak antigen so that the body’s immunity system has a stronger reaction or response to the weak antigen. The most commonly used conjugate vaccine is the Hib conjugate vaccine. Bacterial meningitis from Hib has disappeared from North America, Australia, and Europe since the introduction of Hib vaccines.

The conjugate vaccine market analysis prepared by a leading market research company suggests that the global conjugate vaccines market is expected to expand at a compound annual growth rate (CAGR) of 11.7% and reach approximately USD 87.7 Bn by 2022. The market for conjugate vaccines is segmented into type, disease indication, pathogen, end user and geography.

 Based on disease indication, the market is segmented into pneumococcal, influenza, diphtheria and pertussis (DTP), meningococcal, and others. The Conjugate Vaccine marketforecast suggests that the pneumococcal conjugate vaccine (PCV) occupied 24.66% in 2017 due to the widespread of the pneumococcal disease. Based on the type, the market is bifurcated into monovalent conjugate vaccines and multivalent conjugate vaccines. Based on the end-user, the market is segmented into adults and pediatric vaccines.

Based on the pathogen the market for conjugate vaccines is divided are into the bacterial conjugate vaccine, viral conjugate vaccine, and combination (viral and bacterial) conjugate vaccine.

The largest market for conjugate vaccines has been the Asia Pacific region which occupied 42% of the market share in 2017. Close to its heels, is North America, owing to the widespread immunization programmes. Regions such as Middle East, Latin America, and Africa does not have the required infrastructure and health awareness campaigns which is preventing the growth of the conjugate vaccine market.

View Our Previous Blogs –

1.       https://globalmarketsreport.wordpress.com/2019/03/20/what-are-the-advantages-of-the-global-conjugate-vaccine-market/

2.       https://globalmarketsreport.wordpress.com/2019/03/20/what-are-the-advantages-of-the-global-conjugate-vaccine-market/

3.       3.https://researchonglobalmarkets.jimdofree.com/2019/03/26/how-will-the-growth-of-the-china-5g-market-improve-lives/

4.       4.https://researchonglobalmarkets.jimdofree.com/2019/03/26/what-are-the-key-challenges-faced-by-the-telehealth-industry/

   For more report please visit- Our Report Store
   Contact No- +1-888-831-3350
    Email id- ankita.basu@rogmreports.com
    Contact person- Ankita Basu